In an effort to find potential prognostic gene pairs for breast cancer, we partitioned the patients with breast cancer into two groups, one with a wide-type TP53 gene (hereafter called wtTP53) and the other with somatic mutations in the TP53 gene (called mTP53), and constructed gene correlation networks for the two groups. This evidence concerns the gene TP53 and breast cancer.